INVEST.IN.TEKINSPIRE.
INVEST.IN.TEK supports founders at critical inflection points—strategy, positioning, fundraising readiness, governance, and business growth. We work selectively with teams that need operator judgment, not generic playbooks, across Europe, the Middle East, and APAC.
Direct and co-investment in AI, HealthTech, life sciences, and sustainability—disciplined capital for scalable, technology-led ventures.
We mentor and support companies we build or back—guidance on strategy, governance, and execution from traction through scale.
Founder coaching and cross-border GTM—mentoring and market expansion for teams entering Europe, the Middle East, and APAC.
Market focus
Disciplined impact capital, AI technologies, venture building, and cross-border execution for technology-driven ventures—operator-led across borders.
Direct and co-investment where commercial growth and measurable impact align. We back durable, scalable businesses—not soft positioning.
Operational ML, LLM-enabled products, and automation with defensible commercial models. AI is a major market theme—not an AI-only fund.
Operator-led venture building from conviction through launch and commercial scale—where execution, not capital alone, defines outcomes.
Founder coaching, business coaching, and cross-border GTM—strategic market expansion, partnerships, and go-to-market discipline.
Where the thesis is active. Sector and technology themes where we concentrate capital and operator work.
Capital discipline
Disciplined capital allocation with a value-creation thesis—backing companies and technologies that can deliver commercial performance while contributing to measurable economic, operational, environmental, or social outcomes.
For INVEST.IN.TEK, impact capital is not charity and not communication-layer ESG. It is responsible investment discipline focused on scalable ventures where technology, market need, environmental and social considerations, and sustainable value creation reinforce each other.
Commercial discipline
We look for ventures with credible markets, scalable models, and long-term value potential.
Responsible growth
Environmental and social considerations are evaluated as part of resilience, market relevance, and sustainable value creation.
Technology as enabler
AI technologies, machine learning, LLMs, HealthTech, digital infrastructure, and circular models are focus areas within the broader impact-capital thesis.
Who we work with
We work with decision-makers who need capital, operating support, or cross-border execution—not open-ended consulting or passive sponsorship.
Founders
Technology ventures seeking operator support on GTM, fundraising, governance, and cross-border expansion—from traction through scale.
Investors
Family offices, funds, and co-investors—aligned themes, syndication, and venture dialogue where interests and governance match.
Corporate partners
Companies we team up with on venture programmes and international growth—operator support, deal flow, and cross-border execution with clear milestones.
Strategic partners
Ecosystem partners across Europe and global markets—accelerators, trade agencies, and scale-up programmes that support cross-border execution.
The modern venture mandate is no longer to fund companies that merely participate in the market, but to build the systems the future economy needs.
Core competencies
Active themes within our impact-capital thesis—technology-driven ventures with commercial discipline and measurable outcomes.
Direct investment and venture building in intelligent technology—machine learning, LLM-enabled products, and automation—where defensible economics and cross-border execution matter more than hype.
AI investment. machine learning ventures. LLM products. intelligent automation. AI technologies
Responsible capital allocation in sustainable commerce, resource efficiency, and circular models—where environmental and social considerations, operational efficiency, and durable returns reinforce each other.
sustainability investment. circular economy ventures. sustainable commerce. resource efficiency. sustainable value creation
HealthTech and life sciences—from digital health to regulated healthcare technology—where validation, partnerships, and disciplined cross-border expansion define outcomes.
HealthTech investment. life sciences ventures. digital health. healthcare technology. cross-border HealthTechMandates & dialogue
Impact capital, venture building, founder coaching, and cross-border GTM—for teams where commercial performance and measurable outcomes align.
